Organization · Venture Capital
Bioventure Management
Bioventure Management is a Germany-based investment firm specializing in life sciences, focusing on biotechnology, medical technology, and cell therapies. It operates through a club deal model, providing co-investment opportunities for wealthy families.
Overview
What Bioventure Management does
What Bioventure Management is
Bioventure Management is a Germany-based investment firm specializing in life sciences, focusing on biotechnology, medical technology, and cell therapies. It operates through a club deal model, providing co-investment opportunities for wealthy families.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2001
- Approximate age
- About 25 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Bioventure Management elsewhere
Open the official website or a supported primary organization account.
Capability profile
Bioventure Management as a funder
Investment thesis
Bioventure Management focuses on early-stage life science companies with innovations that offer exceptional value creation potential and significant positive impact on society and patients, particularly in biotechnology, medical technology, and cell therapies.
Focus narrative
Bioventure Management invests in economically strong and socially relevant sectors, including biotechnology, medical technology, and cell therapies. The organization emphasizes high impact and sustainable value creation through a rigorous selection process based on scientific analysis and entrepreneurial experience.
Value beyond capital
Bioventure Management adds value to its portfolio companies through active management by life science experts throughout the entire investment period, leveraging their expertise to guide companies towards successful outcomes.
Terms and economics
- Typical check
- $15,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
- Recorded notable exits
- HMO company and Second exit
Portfolio context
Notable portfolio companies include: REPAIRON GmbH: Develops heart tissue from stem cells for cardiology applications. PROVIREX GmbH: Focuses on genome editing for the treatment of HIV, nearing clinical application. APTARION BIOTECH AG: Works on a novel therapy for severe pneumonia, currently in a Phase 2 study. APHAIA PHARMA AG: Offers a side-effect-free alternative to weight-loss injections, which is innovative, scalable, and patented. DIAMONTECH AG: Develops a non-invasive blood glucose measurement technology that is pain-free and precise.
Common questions
What to know about Bioventure Management
Upseed classifies Bioventure Management under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.